Viewing Study NCT06547203


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-01-08 @ 5:31 AM
Study NCT ID: NCT06547203
Status: RECRUITING
Last Update Posted: 2024-08-09
First Post: 2024-07-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module